Related Experiment Video

Updated: May 31, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction,

Robert A Rose1, Michael Sellan, Jeremy A Simpson

  • 1Department of Physiology, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Circulation. Arrhythmia and Electrophysiology
|July 13, 2011
PubMed

Insights

Chronic iron overload causes bradycardia by reducing Ca(V)1.3 channel function, impacting heart rate and electrical conduction. This study reveals a key mechanism behind iron overload

Area of Science:

  • Cardiovascular Physiology
  • Electrophysiology
  • Iron Metabolism

Background:

  • Chronic iron overload (CIO) is linked to blood disorders like thalassemia and hemochromatosis.
  • Iron-mediated cardiomyopathy, causing contractile and electrical dysfunction (bradycardia, heart block), is a critical survival indicator in CIO patients.

Purpose of the Study:

  • To investigate the impact of chronic iron overload on sinoatrial node (SAN) function using a mouse model.
  • To elucidate the specific ion channel mechanisms underlying iron-induced cardiac electrical disturbances.

Main Methods:

  • Utilized a mouse model of chronic iron overload.
  • Measured heart rate in conscious, anesthetized, and isolated perfused hearts.
  • Assessed sinoatrial node myocyte action potentials and L-type calcium currents (I(Ca,L)).
  • Quantified Ca(V)1.3 mRNA levels and utilized Ca(V)1.3 knockout mice.

Main Results:

  • CIO reduced heart rate by approximately 20% in mice, indicating intrinsic SAN dysfunction.
  • Reduced I(Ca,L) densities and rightward shifts in activation were observed in SAN myocytes from CIO mice.
  • Elevated iron preferentially suppressed Ca(V)1.3 channel function, evidenced by reduced Ca(V)1.3 mRNA and lack of heart rate decrease in Ca(V)1.3 knockout mice.
  • CIO induced PR-interval prolongation, heart block, and atrial fibrillation.

Conclusions:

  • Chronic iron overload selectively impairs Ca(V)1.3-mediated L-type calcium currents in the heart.
  • This selective reduction in I(Ca,L) leads to bradycardia, slowed electrical conduction, and atrial fibrillation.
  • The findings identify Ca(V)1.3 channel dysfunction as a critical mechanism in iron overload-induced cardiac electrophysiological abnormalities.
Abstract

More Related Videos

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Isolation of Atrial Myocytes from Adult Mice08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...